Cutting-Edge Grants Boost Orgenesis Consortium's Innovative Projects
March 15, 2024, 5:27 pm
Orgenesis Consortium, a leader in advanced therapy medicinal products (ATMP) manufacturing, has secured two significant grants from the Walloon Government in Belgium. The first €2.0M EUR grant will support the MAIDAM AI Project, focusing on monitoring decentralized ATMP manufacturing. The second €1.5M EUR grant will fuel the EXOFASTTRACK Project, dedicated to accelerating the development of therapeutic exosomes. These grants mark a major milestone for Orgenesis Consortium, propelling their cutting-edge projects to new heights in the field of regenerative medicine.